Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
03/1998
03/12/1998CA2263686A1 Methods for in vivo reduction of iron levels and compositions useful therefor
03/12/1998CA2256716A1 Matrix metalloproteinase inhibitors and their therapeutic uses
03/11/1998EP0827746A1 Carbazole analogues as selective B3 adrenergic agonists
03/11/1998EP0827743A1 Use of histone decarboxylase inhibitors for treating fibrosis
03/11/1998EP0827742A1 Use of histone deacetylase inhibitors for treating fribosis or cirrhosis
03/11/1998EP0827500A1 (2-morpholinylmethyl)benzamide derivatives
03/11/1998EP0785933B1 Indole derivatives as 5ht1-like agonists
03/11/1998EP0636125B1 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists
03/11/1998CN1175944A 1 -aryl -2 -acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
03/11/1998CN1175898A Method for preparing preparation for bleaching teeth or for treating skin complaints and mucous membrane disorders
03/11/1998CN1175463A Anti-senility hypolipemic Chinese medicine liquor
03/11/1998CN1175459A Specific infusion for hepatitis B and producing process thereof
03/11/1998CN1175429A Medicine for treatment of constipation
03/11/1998CN1175411A Use of dicafeoyl quininic acid in treatment of hepatitis B and diseases associated with retrovirus and cafeoyl quininic acid derivs.
03/11/1998CN1175399A Fluorinated foam
03/11/1998CN1037682C Process for preparing 2 -hydroxymethyl -5 -(5 -fluorocytosin -1 -yl) -1 ,3 -oxathiolane
03/10/1998US5726305 Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
03/10/1998US5726200 Treatment of obesity, gastrointestinal disorders, tumors, drug withdrawal; useful as antipsychotic, antianxiety, antiulcer agents;
03/10/1998US5726187 N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists
03/10/1998CA2043136C N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
03/05/1998WO1998008877A1 Chitosan derivatives, process for producing the same and uses of the same
03/05/1998WO1998008872A1 Glp-2 derivatives
03/05/1998WO1998008853A1 Phosphinic acid amides as matrix metalloprotease inhibitors
03/05/1998WO1998008850A1 Spirocyclic metalloprotease inhibitors
03/05/1998WO1998008847A1 Substituted 6,5-hetero-bicyclic derivatives
03/05/1998WO1998008846A1 Substituted 6,6-hetero-bicyclic derivatives
03/05/1998WO1998008834A1 Benzylamine derivatives, their preparation and their application in therapeutics
03/05/1998WO1998008827A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008826A1 Piperazino derivatives as neurokinin antagonists
03/05/1998WO1998008825A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998WO1998008823A1 Heterocyclic metalloprotease inhibitors
03/05/1998WO1998008822A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998WO1998008815A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998WO1998008814A1 Bidentate metalloprotease inhibitors
03/05/1998WO1998008529A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008528A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998WO1998008512A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
03/05/1998WO1998008503A1 Therapeutic methods and compositions involving isoflavones
03/05/1998WO1998001554A3 Secreted proteins and polynucleotides encoding them
03/05/1998CA2265049A1 Therapeutic methods and compositions involving isoflavones
03/05/1998CA2264309A1 Method of inhibiting fibrosis with a somatostatin agonist
03/05/1998CA2264266A1 1,3-diheterocyclic metalloprotease inhibitors
03/05/1998CA2264045A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2264044A1 Spirocyclic metalloprotease inhibitors
03/05/1998CA2263932A1 1,4-heterocyclic metalloprotease inhibitors
03/05/1998CA2263928A1 Substituted cyclic amine metalloprotease inhibitors
03/05/1998CA2263917A1 Heterocyclic metalloprotease inhibitors
03/05/1998CA2263914A1 Bidentate metalloprotease inhibitors
03/05/1998CA2263826A1 Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor
03/04/1998EP0826774A2 Staphylococcal Fab I enoyl-ACP reductase
03/04/1998EP0826374A2 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
03/04/1998EP0826311A1 Oral composition for animals
03/04/1998EP0826048A1 Pancreas-derived serpin
03/04/1998EP0826000A1 Peptide compounds which inhibit metalloproteinase and tnf liberation and their therapeutic uses
03/04/1998EP0825991A1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists
03/04/1998EP0825869A1 Pharmaceutical composition comprising lactobacillus plantarum and arginine
03/04/1998EP0825868A1 Method of preventing or treating alimentary tract damage due to chemotherapy or radiation
03/04/1998EP0825858A1 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids
03/04/1998CN1175260A Induction of cytotoxic t -lymphocyte responses
03/04/1998CN1174742A Complex cow's milk gamma globulin and the making method thereof
03/04/1998CN1174717A Traditional Chinese medicine for curing gastric disease
03/04/1998CN1174709A Traditional Chinese set prescription for curing gastrointestinal tract disease and gynopathy
03/04/1998CN1174703A Method for producing injection used for curing fowls and animals dysentery and diarrhea
03/03/1998US5723606 Condensed benzazepine derivative and pharmaceutical composition thereof
03/03/1998US5723489 Aryloxypropanolamine beta 3 adrenergic agonists
03/03/1998US5723483 Substituted 1-phenyl-3-pyrazolecarboxamides active on neurotensin receptors, their preparation and pharmaceutical compositions containing them
03/03/1998US5723472 Aminobenzoic acid derivatives
03/03/1998US5723449 Antisecretory agents and anticarcinogenic agents
03/03/1998US5723444 Enzyme inhibitors and anticoagulants
03/03/1998US5723315 Secreted proteins and polynucleotides encoding them
03/03/1998US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
02/1998
02/28/1998CA2212954A1 Pharmaceutical composition for prophylaxis and/or treatment of apoptosis-related diseases
02/26/1998WO1998007859A2 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007853A1 Secreted proteins and polynucleotides encoding them
02/26/1998WO1998007841A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
02/26/1998WO1998007718A1 Non-peptide bombesin receptor antagonists
02/26/1998WO1998007697A1 Arylsulfonylamino hydroxamic acid derivatives
02/26/1998WO1998007694A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
02/26/1998WO1998007449A2 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect
02/26/1998WO1998007437A1 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B COMPRISING EXTRACT OF PHYLLANTHUS USSURIENSIS AND/OR $i(PHYLLANTHUS URINARIA)
02/26/1998WO1998000115A3 Stable drug form for oral administration and process for the preparation thereof
02/26/1998WO1998000114A3 Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
02/26/1998DE19633968A1 Laxative composition giving improved intestinal function
02/26/1998DE19633268A1 Polymere Gallensäure-Resorptionsinhibitoren mit gleichzeitiger Gallensäure-Adsorberwirkung Polymeric bile acid Resorptionsinhibitoren with concomitant bile acid Adsorberwirkung
02/26/1998CA2264284A1 Arylsulfonylamino hydroxamic acid derivatives
02/26/1998CA2264192A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2264064A1 Imidazole compounds, compositions and use
02/26/1998CA2263875A1 Secreted proteins and polynucleotides encoding them
02/26/1998CA2263671A1 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect
02/26/1998CA2262817A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
02/26/1998CA2255966A1 Non-peptide bombesin receptor antagonists
02/25/1998EP0824910A2 Use of a Krill Enzyme for the Treatment of Dental Plaque
02/25/1998EP0824546A2 Angiostatin fragments and aggregate angiostatin and methods of use
02/25/1998EP0824544A1 Peptidyl compounds which inhibit metalloproteinase and tnf liberation and their therapeutic use
02/25/1998EP0824543A1 Peptide compounds which inhibit metalloproteinase and tnf liberation, and their therapeutic use
02/25/1998EP0824530A1 Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
02/25/1998EP0824529A1 Benzothiazoles and benzoxazoles, as well as drugs containing them, their use and methods of preparing them
02/25/1998EP0824357A1 The use of epidermal growth factor as a gastrointestinal therapeutic agent
02/25/1998CN1174051A Medicine for lithiasis
02/24/1998US5721349 Genetically altered mutant strain
1 ... 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 ... 1258